2016 Gastrointestinal Cancers Symposium: update on pancreatic cancer.
作者信息
Russo Suzanne, Saif Muhammad Wasif
机构信息
Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH (Suzanne Russo), USA.
Department of Medicine and Cancer Center, Tufts Medical Center, Boston, MA (Muhammad Wasif Saif), USA.
出版信息
Ann Gastroenterol. 2016 Apr-Jun;29(2):238-40. doi: 10.20524/aog.2016.0024.
Abstract
摘要
相似文献
1
2016 Gastrointestinal Cancers Symposium: update on pancreatic cancer.2016年胃肠道癌症研讨会：胰腺癌最新进展
Ann Gastroenterol. 2016 Apr-Jun;29(2):238-40. doi: 10.20524/aog.2016.0024.
2
3
Translational challenges from the 2014 Gastrointestinal Cancers Symposium: toward a true tailored therapy through effective research.从 2014 年胃肠道肿瘤研讨会看转化医学的挑战：通过有效的研究实现真正的个体化治疗。
Future Oncol. 2014 May;10(7):1125-8. doi: 10.2217/fon.14.54.
4
An update on surgical staging of patients with pancreatic cancer.胰腺癌患者手术分期的最新进展。
JOP. 2012 Mar 10;13(2):143-6.
5
6
7
BRCA and pancreatic cancer: selection of chemotherapy.BRCA与胰腺癌：化疗的选择
JOP. 2012 Mar 10;13(2):180-1.
8
9
ASCO Gastrointestinal Cancers Symposium And San Antonio Breast Cancer Symposium.美国临床肿瘤学会胃肠道癌症研讨会及圣安东尼奥乳腺癌研讨会
P T. 2018 Mar;43(3):171-178.
引用本文的文献
1
Small interfering RNA: From designing to therapeutic in cancer.小干扰RNA：从设计到癌症治疗
J Genet Eng Biotechnol. 2025 Jun;23(2):100484. doi: 10.1016/j.jgeb.2025.100484. Epub 2025 Apr 3.
2
Complexed hyaluronic acid-based nanoparticles in cancer therapy and diagnosis: Research trends by natural language processing.基于复合透明质酸的纳米颗粒在癌症治疗与诊断中的应用：通过自然语言处理的研究趋势
Heliyon. 2024 Dec 18;11(1):e41246. doi: 10.1016/j.heliyon.2024.e41246. eCollection 2025 Jan 15.
3
A Comprehensive Review of Small Interfering RNAs (siRNAs): Mechanism, Therapeutic Targets, and Delivery Strategies for Cancer Therapy.小干扰 RNA（siRNA）的全面综述：癌症治疗的机制、治疗靶点和递送策略。
Int J Nanomedicine. 2023 Dec 13;18:7605-7635. doi: 10.2147/IJN.S436038. eCollection 2023.
4
Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment.基于小干扰RNA的纳米疗法在癌症治疗中的临床进展
Pharmaceutics. 2021 Jul 2;13(7):1009. doi: 10.3390/pharmaceutics13071009.
5
Established Models and New Paradigms for Hypoxia-Driven Cancer-Associated Bone Disease.缺氧驱动的癌症相关骨病的既定模型和新范式。
Calcif Tissue Int. 2018 Feb;102(2):163-173. doi: 10.1007/s00223-017-0352-6. Epub 2017 Nov 2.
本文引用的文献
1
A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial.随机、双盲、Ⅱ期试验：吉西他滨联合nab-紫杉醇加阿帕瑟森或安慰剂治疗转移性胰腺癌患者：RAINIER 试验。
Oncologist. 2017 Dec;22(12):1427-e129. doi: 10.1634/theoncologist.2017-0066. Epub 2017 Sep 21.
2
Combination gemcitabine/cisplatin therapy and ERCC1 expression for resected pancreatic adenocarcinoma: Results of a Phase II prospective trial.吉西他滨/顺铂联合治疗与ERCC1表达在可切除胰腺癌中的应用：一项II期前瞻性试验的结果
J Surg Oncol. 2016 Sep;114(3):336-41. doi: 10.1002/jso.24317. Epub 2016 Aug 8.
3
A phase I trial of cabozantinib and gemcitabine in advanced pancreatic cancer.卡博替尼与吉西他滨联合用于晚期胰腺癌的I期试验。
Invest New Drugs. 2016 Dec;34(6):733-739. doi: 10.1007/s10637-016-0376-1. Epub 2016 Jul 21.
Zotero 插件